New Deal
David Ying Chen
Executive Director, Head of M&A at EPIPHRON CAPITAL
Investor
Deal Bio
Yisheng Biopharma
Adjuvant Capital
£92m
12 dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.